1 Drug Coated Stent Market Overview
    1.1 Product Overview and Scope of Drug Coated Stent
    1.2 Drug Coated Stent Segment by Type
        1.2.1 Global Drug Coated Stent Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Everolimus-Coated Stent
        1.2.3 Zotarolimus-Coated Stent
        1.2.4 Ridaforolimus-Coated Stent
        1.2.5 SYNERGY Coated Stent
        1.2.6 Orsiro Coated Stent
    1.3 Drug Coated Stent Segment by Application
        1.3.1 Global Drug Coated Stent Sales Comparison by Application: (2022-2028)
        1.3.2 Angioplasty
        1.3.3 Restenosis
    1.4 Global Drug Coated Stent Market Size Estimates and Forecasts
        1.4.1 Global Drug Coated Stent Revenue 2017-2028
        1.4.2 Global Drug Coated Stent Sales 2017-2028
        1.4.3 Drug Coated Stent Market Size by Region: 2017 Versus 2021 Versus 2028
2 Drug Coated Stent Market Competition by Manufacturers
    2.1 Global Drug Coated Stent Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Drug Coated Stent Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Drug Coated Stent Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Drug Coated Stent Manufacturing Sites, Area Served, Product Type
    2.5 Drug Coated Stent Market Competitive Situation and Trends
        2.5.1 Drug Coated Stent Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Drug Coated Stent Players Market Share by Revenue
        2.5.3 Global Drug Coated Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Coated Stent Retrospective Market Scenario by Region
    3.1 Global Drug Coated Stent Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Drug Coated Stent Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Drug Coated Stent Market Facts & Figures by Country
        3.3.1 North America Drug Coated Stent Sales by Country
        3.3.2 North America Drug Coated Stent Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Drug Coated Stent Market Facts & Figures by Country
        3.4.1 Europe Drug Coated Stent Sales by Country
        3.4.2 Europe Drug Coated Stent Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Drug Coated Stent Market Facts & Figures by Region
        3.5.1 Asia Pacific Drug Coated Stent Sales by Region
        3.5.2 Asia Pacific Drug Coated Stent Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Drug Coated Stent Market Facts & Figures by Country
        3.6.1 Latin America Drug Coated Stent Sales by Country
        3.6.2 Latin America Drug Coated Stent Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Drug Coated Stent Market Facts & Figures by Country
        3.7.1 Middle East and Africa Drug Coated Stent Sales by Country
        3.7.2 Middle East and Africa Drug Coated Stent Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Drug Coated Stent Historic Market Analysis by Type
    4.1 Global Drug Coated Stent Sales Market Share by Type (2017-2022)
    4.2 Global Drug Coated Stent Revenue Market Share by Type (2017-2022)
    4.3 Global Drug Coated Stent Price by Type (2017-2022)
5 Global Drug Coated Stent Historic Market Analysis by Application
    5.1 Global Drug Coated Stent Sales Market Share by Application (2017-2022)
    5.2 Global Drug Coated Stent Revenue Market Share by Application (2017-2022)
    5.3 Global Drug Coated Stent Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Biosensors International
        6.1.1 Biosensors International Corporation Information
        6.1.2 Biosensors International Description and Business Overview
        6.1.3 Biosensors International Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Biosensors International Drug Coated Stent Product Portfolio
        6.1.5 Biosensors International Recent Developments/Updates
    6.2 Abbott Laboratories
        6.2.1 Abbott Laboratories Corporation Information
        6.2.2 Abbott Laboratories Description and Business Overview
        6.2.3 Abbott Laboratories Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Abbott Laboratories Drug Coated Stent Product Portfolio
        6.2.5 Abbott Laboratories Recent Developments/Updates
    6.3 Advantec Vascular
        6.3.1 Advantec Vascular Corporation Information
        6.3.2 Advantec Vascular Description and Business Overview
        6.3.3 Advantec Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Advantec Vascular Drug Coated Stent Product Portfolio
        6.3.5 Advantec Vascular Recent Developments/Updates
    6.4 B. Braun
        6.4.1 B. Braun Corporation Information
        6.4.2 B. Braun Description and Business Overview
        6.4.3 B. Braun Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 B. Braun Drug Coated Stent Product Portfolio
        6.4.5 B. Braun Recent Developments/Updates
    6.5 Biosensors
        6.5.1 Biosensors Corporation Information
        6.5.2 Biosensors Description and Business Overview
        6.5.3 Biosensors Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Biosensors Drug Coated Stent Product Portfolio
        6.5.5 Biosensors Recent Developments/Updates
    6.6 Biotronik
        6.6.1 Biotronik Corporation Information
        6.6.2 Biotronik Description and Business Overview
        6.6.3 Biotronik Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Biotronik Drug Coated Stent Product Portfolio
        6.6.5 Biotronik Recent Developments/Updates
    6.7 Blue Medical
        6.6.1 Blue Medical Corporation Information
        6.6.2 Blue Medical Description and Business Overview
        6.6.3 Blue Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Blue Medical Drug Coated Stent Product Portfolio
        6.7.5 Blue Medical Recent Developments/Updates
    6.8 Boston Scientific
        6.8.1 Boston Scientific Corporation Information
        6.8.2 Boston Scientific Description and Business Overview
        6.8.3 Boston Scientific Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Boston Scientific Drug Coated Stent Product Portfolio
        6.8.5 Boston Scientific Recent Developments/Updates
    6.9 DISA Vascular
        6.9.1 DISA Vascular Corporation Information
        6.9.2 DISA Vascular Description and Business Overview
        6.9.3 DISA Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 DISA Vascular Drug Coated Stent Product Portfolio
        6.9.5 DISA Vascular Recent Developments/Updates
    6.10 Essen
        6.10.1 Essen Corporation Information
        6.10.2 Essen Description and Business Overview
        6.10.3 Essen Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Essen Drug Coated Stent Product Portfolio
        6.10.5 Essen Recent Developments/Updates
    6.11 Medtronic Vascular
        6.11.1 Medtronic Vascular Corporation Information
        6.11.2 Medtronic Vascular Drug Coated Stent Description and Business Overview
        6.11.3 Medtronic Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Medtronic Vascular Drug Coated Stent Product Portfolio
        6.11.5 Medtronic Vascular Recent Developments/Updates
    6.12 MicroPort Medical
        6.12.1 MicroPort Medical Corporation Information
        6.12.2 MicroPort Medical Drug Coated Stent Description and Business Overview
        6.12.3 MicroPort Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 MicroPort Medical Drug Coated Stent Product Portfolio
        6.12.5 MicroPort Medical Recent Developments/Updates
    6.13 MIV Therapeutics
        6.13.1 MIV Therapeutics Corporation Information
        6.13.2 MIV Therapeutics Drug Coated Stent Description and Business Overview
        6.13.3 MIV Therapeutics Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 MIV Therapeutics Drug Coated Stent Product Portfolio
        6.13.5 MIV Therapeutics Recent Developments/Updates
    6.14 Orbusneich
        6.14.1 Orbusneich Corporation Information
        6.14.2 Orbusneich Drug Coated Stent Description and Business Overview
        6.14.3 Orbusneich Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Orbusneich Drug Coated Stent Product Portfolio
        6.14.5 Orbusneich Recent Developments/Updates
    6.15 Promed Medical
        6.15.1 Promed Medical Corporation Information
        6.15.2 Promed Medical Drug Coated Stent Description and Business Overview
        6.15.3 Promed Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Promed Medical Drug Coated Stent Product Portfolio
        6.15.5 Promed Medical Recent Developments/Updates
    6.16 Relisys Medical
        6.16.1 Relisys Medical Corporation Information
        6.16.2 Relisys Medical Drug Coated Stent Description and Business Overview
        6.16.3 Relisys Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Relisys Medical Drug Coated Stent Product Portfolio
        6.16.5 Relisys Medical Recent Developments/Updates
    6.17 Reva Medical
        6.17.1 Reva Medical Corporation Information
        6.17.2 Reva Medical Drug Coated Stent Description and Business Overview
        6.17.3 Reva Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Reva Medical Drug Coated Stent Product Portfolio
        6.17.5 Reva Medical Recent Developments/Updates
    6.18 Sahajanand
        6.18.1 Sahajanand Corporation Information
        6.18.2 Sahajanand Drug Coated Stent Description and Business Overview
        6.18.3 Sahajanand Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Sahajanand Drug Coated Stent Product Portfolio
        6.18.5 Sahajanand Recent Developments/Updates
    6.19 Sino Medical
        6.19.1 Sino Medical Corporation Information
        6.19.2 Sino Medical Drug Coated Stent Description and Business Overview
        6.19.3 Sino Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Sino Medical Drug Coated Stent Product Portfolio
        6.19.5 Sino Medical Recent Developments/Updates
    6.20 Sorin
        6.20.1 Sorin Corporation Information
        6.20.2 Sorin Drug Coated Stent Description and Business Overview
        6.20.3 Sorin Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Sorin Drug Coated Stent Product Portfolio
        6.20.5 Sorin Recent Developments/Updates
    6.21 Terumo Medical
        6.21.1 Terumo Medical Corporation Information
        6.21.2 Terumo Medical Drug Coated Stent Description and Business Overview
        6.21.3 Terumo Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Terumo Medical Drug Coated Stent Product Portfolio
        6.21.5 Terumo Medical Recent Developments/Updates
7 Drug Coated Stent Manufacturing Cost Analysis
    7.1 Drug Coated Stent Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Drug Coated Stent
    7.4 Drug Coated Stent Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Drug Coated Stent Distributors List
    8.3 Drug Coated Stent Customers
9 Drug Coated Stent Market Dynamics
    9.1 Drug Coated Stent Industry Trends
    9.2 Drug Coated Stent Market Drivers
    9.3 Drug Coated Stent Market Challenges
    9.4 Drug Coated Stent Market Restraints
10 Global Market Forecast
    10.1 Drug Coated Stent Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Drug Coated Stent by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Drug Coated Stent by Type (2023-2028)
    10.2 Drug Coated Stent Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Drug Coated Stent by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Drug Coated Stent by Application (2023-2028)
    10.3 Drug Coated Stent Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Drug Coated Stent by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Drug Coated Stent by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Drug Coated Stent Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Drug Coated Stent Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Drug Coated Stent Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Drug Coated Stent Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Drug Coated Stent Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Drug Coated Stent Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Drug Coated Stent Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Drug Coated Stent Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Drug Coated Stent Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Drug Coated Stent Manufacturing Sites and Area Served
    Table 11. Manufacturers Drug Coated Stent Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Drug Coated Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Coated Stent as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Drug Coated Stent Sales by Region (2017-2022) & (K Units)
    Table 16. Global Drug Coated Stent Sales Market Share by Region (2017-2022)
    Table 17. Global Drug Coated Stent Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Drug Coated Stent Revenue Market Share by Region (2017-2022)
    Table 19. North America Drug Coated Stent Sales by Country (2017-2022) & (K Units)
    Table 20. North America Drug Coated Stent Sales Market Share by Country (2017-2022)
    Table 21. North America Drug Coated Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Drug Coated Stent Revenue Market Share by Country (2017-2022)
    Table 23. Europe Drug Coated Stent Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Drug Coated Stent Sales Market Share by Country (2017-2022)
    Table 25. Europe Drug Coated Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Drug Coated Stent Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Drug Coated Stent Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Drug Coated Stent Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Drug Coated Stent Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Drug Coated Stent Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Drug Coated Stent Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Drug Coated Stent Sales Market Share by Country (2017-2022)
    Table 33. Latin America Drug Coated Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Drug Coated Stent Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Drug Coated Stent Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Drug Coated Stent Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Drug Coated Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Drug Coated Stent Revenue Market Share by Country (2017-2022)
    Table 39. Global Drug Coated Stent Sales by Type (2017-2022) & (K Units)
    Table 40. Global Drug Coated Stent Sales Market Share by Type (2017-2022)
    Table 41. Global Drug Coated Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Drug Coated Stent Revenue Share by Type (2017-2022)
    Table 43. Global Drug Coated Stent Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Drug Coated Stent Sales (K Units) by Application (2017-2022)
    Table 45. Global Drug Coated Stent Sales Market Share by Application (2017-2022)
    Table 46. Global Drug Coated Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Drug Coated Stent Revenue Share by Application (2017-2022)
    Table 48. Global Drug Coated Stent Price by Application (2017-2022) & (US$/Unit)
    Table 49. Biosensors International Corporation Information
    Table 50. Biosensors International Description and Business Overview
    Table 51. Biosensors International Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Biosensors International Drug Coated Stent Product
    Table 53. Biosensors International Recent Developments/Updates
    Table 54. Abbott Laboratories Corporation Information
    Table 55. Abbott Laboratories Description and Business Overview
    Table 56. Abbott Laboratories Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Abbott Laboratories Drug Coated Stent Product
    Table 58. Abbott Laboratories Recent Developments/Updates
    Table 59. Advantec Vascular Corporation Information
    Table 60. Advantec Vascular Description and Business Overview
    Table 61. Advantec Vascular Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Advantec Vascular Drug Coated Stent Product
    Table 63. Advantec Vascular Recent Developments/Updates
    Table 64. B. Braun Corporation Information
    Table 65. B. Braun Description and Business Overview
    Table 66. B. Braun Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. B. Braun Drug Coated Stent Product
    Table 68. B. Braun Recent Developments/Updates
    Table 69. Biosensors Corporation Information
    Table 70. Biosensors Description and Business Overview
    Table 71. Biosensors Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Biosensors Drug Coated Stent Product
    Table 73. Biosensors Recent Developments/Updates
    Table 74. Biotronik Corporation Information
    Table 75. Biotronik Description and Business Overview
    Table 76. Biotronik Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Biotronik Drug Coated Stent Product
    Table 78. Biotronik Recent Developments/Updates
    Table 79. Blue Medical Corporation Information
    Table 80. Blue Medical Description and Business Overview
    Table 81. Blue Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Blue Medical Drug Coated Stent Product
    Table 83. Blue Medical Recent Developments/Updates
    Table 84. Boston Scientific Corporation Information
    Table 85. Boston Scientific Description and Business Overview
    Table 86. Boston Scientific Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Boston Scientific Drug Coated Stent Product
    Table 88. Boston Scientific Recent Developments/Updates
    Table 89. DISA Vascular Corporation Information
    Table 90. DISA Vascular Description and Business Overview
    Table 91. DISA Vascular Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. DISA Vascular Drug Coated Stent Product
    Table 93. DISA Vascular Recent Developments/Updates
    Table 94. Essen Corporation Information
    Table 95. Essen Description and Business Overview
    Table 96. Essen Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Essen Drug Coated Stent Product
    Table 98. Essen Recent Developments/Updates
    Table 99. Medtronic Vascular Corporation Information
    Table 100. Medtronic Vascular Description and Business Overview
    Table 101. Medtronic Vascular Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Medtronic Vascular Drug Coated Stent Product
    Table 103. Medtronic Vascular Recent Developments/Updates
    Table 104. MicroPort Medical Corporation Information
    Table 105. MicroPort Medical Description and Business Overview
    Table 106. MicroPort Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. MicroPort Medical Drug Coated Stent Product
    Table 108. MicroPort Medical Recent Developments/Updates
    Table 109. MIV Therapeutics Corporation Information
    Table 110. MIV Therapeutics Description and Business Overview
    Table 111. MIV Therapeutics Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. MIV Therapeutics Drug Coated Stent Product
    Table 113. MIV Therapeutics Recent Developments/Updates
    Table 114. Orbusneich Corporation Information
    Table 115. Orbusneich Description and Business Overview
    Table 116. Orbusneich Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Orbusneich Drug Coated Stent Product
    Table 118. Orbusneich Recent Developments/Updates
    Table 119. Promed Medical Corporation Information
    Table 120. Promed Medical Description and Business Overview
    Table 121. Promed Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Promed Medical Drug Coated Stent Product
    Table 123. Promed Medical Recent Developments/Updates
    Table 124. Relisys Medical Corporation Information
    Table 125. Relisys Medical Description and Business Overview
    Table 126. Relisys Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Relisys Medical Drug Coated Stent Product
    Table 128. Relisys Medical Recent Developments/Updates
    Table 129. Reva Medical Corporation Information
    Table 130. Reva Medical Description and Business Overview
    Table 131. Reva Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Reva Medical Drug Coated Stent Product
    Table 133. Reva Medical Recent Developments/Updates
    Table 134. Sahajanand Corporation Information
    Table 135. Sahajanand Description and Business Overview
    Table 136. Sahajanand Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. Sahajanand Drug Coated Stent Product
    Table 138. Sahajanand Recent Developments/Updates
    Table 139. Sino Medical Corporation Information
    Table 140. Sino Medical Description and Business Overview
    Table 141. Sino Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. Sino Medical Drug Coated Stent Product
    Table 143. Sino Medical Recent Developments/Updates
    Table 144. Sorin Corporation Information
    Table 145. Sorin Description and Business Overview
    Table 146. Sorin Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 147. Sorin Drug Coated Stent Product
    Table 148. Sorin Recent Developments/Updates
    Table 149. Terumo Medical Corporation Information
    Table 150. Terumo Medical Description and Business Overview
    Table 151. Terumo Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 152. Terumo Medical Drug Coated Stent Product
    Table 153. Terumo Medical Recent Developments/Updates
    Table 154. Production Base and Market Concentration Rate of Raw Material
    Table 155. Key Suppliers of Raw Materials
    Table 156. Drug Coated Stent Distributors List
    Table 157. Drug Coated Stent Customers List
    Table 158. Drug Coated Stent Market Trends
    Table 159. Drug Coated Stent Market Drivers
    Table 160. Drug Coated Stent Market Challenges
    Table 161. Drug Coated Stent Market Restraints
    Table 162. Global Drug Coated Stent Sales Forecast by Type (2023-2028) & (K Units)
    Table 163. Global Drug Coated Stent Sales Market Share Forecast by Type (2023-2028)
    Table 164. Global Drug Coated Stent Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 165. Global Drug Coated Stent Revenue Market Share Forecast by Type (2023-2028)
    Table 166. Global Drug Coated Stent Sales Forecast by Application (2023-2028) & (K Units)
    Table 167. Global Drug Coated Stent Sales Market Share Forecast by Application (2023-2028)
    Table 168. Global Drug Coated Stent Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 169. Global Drug Coated Stent Revenue Market Share Forecast by Application (2023-2028)
    Table 170. Global Drug Coated Stent Sales Forecast by Region (2023-2028) & (K Units)
    Table 171. Global Drug Coated Stent Sales Market Share Forecast by Region (2023-2028)
    Table 172. Global Drug Coated Stent Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 173. Global Drug Coated Stent Revenue Market Share Forecast by Region (2023-2028)
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Drug Coated Stent
    Figure 2. Global Drug Coated Stent Market Share by Type in 2021 & 2028
    Figure 3. Everolimus-Coated Stent Product Picture
    Figure 4. Zotarolimus-Coated Stent Product Picture
    Figure 5. Ridaforolimus-Coated Stent Product Picture
    Figure 6. SYNERGY Coated Stent Product Picture
    Figure 7. Orsiro Coated Stent Product Picture
    Figure 8. Global Drug Coated Stent Market Share by Application in 2021 & 2028
    Figure 9. Angioplasty
    Figure 10. Restenosis
    Figure 11. Global Drug Coated Stent Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Drug Coated Stent Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Drug Coated Stent Sales (2017-2028) & (K Units)
    Figure 14. Drug Coated Stent Sales Share by Manufacturers in 2021
    Figure 15. Global Drug Coated Stent Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Drug Coated Stent Players: Market Share by Revenue in 2021
    Figure 17. Drug Coated Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Drug Coated Stent Sales Market Share by Region (2017-2022)
    Figure 19. Global Drug Coated Stent Sales Market Share by Region in 2021
    Figure 20. Global Drug Coated Stent Revenue Market Share by Region (2017-2022)
    Figure 21. Global Drug Coated Stent Revenue Market Share by Region in 2021
    Figure 22. United States Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Colombia Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Drug Coated Stent Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Drug Coated Stent by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Drug Coated Stent
    Figure 47. Manufacturing Process Analysis of Drug Coated Stent
    Figure 48. Drug Coated Stent Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed